These findings demonstrate the exquisite ability of GATA3 to attenuate the malignant properties of bladder cancer as well as breast cancer and raise the possibility that GATA3 or its downstream genes could be therapeutic targets in cancer therapy. This evidence concerns the gene GATA3 and cancer.